TRANSCUTANEOUS DRUG-DELIVERY - A PRACTICAL REVIEW

被引:49
作者
BERTI, JJ
LIPSKY, JJ
机构
[1] MAYO CLIN & MAYO FDN,DEPT PHARM,CLIN PHARMACOL UNIT,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN 55905
关键词
D O I
10.4065/70.6.581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the advantages, disadvantages, practical considerations, and future developments of transcutaneous drug delivery. Material and Methods: The physiochemical properties of the drug preparation that are factors in the effectiveness of transcutaneous transport are drug stability or volatility, use of a solvent carrier or vehicle, use of a penetration enhancer, and type of delivery device, Because a drug should remain on the skin without evaporating or becoming otherwise inactive, it is suspended in a vehicle-any gel, lotion, or paste used to apply the drug to the skin, Penetration enhancers include several compounds that are mixed into vehicles to alter the molecular environment of the epidermis and facilitate absorption, The delivery system itself occasio;nally proves to be the ultimate determinant of transdermal drug flow. Results: The advantages of transcutaneous drug delivery are avoidance of the gastrointestinal tract and hepatic first-pass biotransformation acid metabolism, control of absorption, availability of multiple skin sites to avoid local irritation and toxicity, and improved patient compliance, The disadvantages include the potential for localized irritant and allergic cutaneous reactions, systemic toxicity, and difficulties associated with the time necessary for a drug to diffuse through the skin. Conclusion: Transdermal drug regimens are safe and effective, They provide clinicians the opportunity to offer more therapeutic options to their patients to optimize their care.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 42 条
  • [1] Sams WM, Structure and function of the skin, Principles and Practice of Dermatology, pp. 3-14, (1990)
  • [2] Potts RO, Bommannan DB, Guy RH, Percutaneous absorption, Pharmacology of the Skin, pp. 13-27, (1992)
  • [3] Elias PM, Epidermal lipids, barrier function, and desquamation, Journal of Investigative Dermatology, 80, pp. 44s-49s, (1983)
  • [4] Elias PM, Role of lipids in barrier function of the skin, Pharmacology of the Skin, pp. 29-38, (1992)
  • [5] Ranade VV, Drug delivery systems. 6. Transdermal drug delivery, J Clin Pharmacol, 31, pp. 401-418, (1991)
  • [6] Izumoto T, Aioi A, Uenoyama S, Kuriyama K, Azuma M, Relationship between the transference of a drug from a transdermal patch and the physicochemical properties, Chem Pharm Bull, 40, pp. 456-458, (1992)
  • [7] Jamoulle J-C, Schaefer H, Topical modalities, Dermatology in General Medicine, 2, pp. 2829-2937, (1993)
  • [8] Wester RC, Maibach, Percutaneous absorption of drugs [published erratum appears in Clin Pharmacokinel 1993
  • [9] 24:70], Clin Pharmacokinet, 23, pp. 253-266, (1992)
  • [10] Singh S, Singh J, Transdermal drug delivery by passive diffusion and iontophoresis: a review, Mcd Res Rev, 13, pp. 569-621, (1993)